Cargando…
Binaural acoustic stimulation in patients with Parkinson’s disease
Acoustic stimulation can improve motor symptoms in Parkinson’s disease (PD) and might therefore represent a potential non-invasive treatment option. Scalp electroencephalography studies in healthy subjects indicate that specifically binaural beat stimulation (BBS) in the gamma frequency range is ass...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196363/ https://www.ncbi.nlm.nih.gov/pubmed/37213909 http://dx.doi.org/10.3389/fneur.2023.1167006 |
_version_ | 1785044336074817536 |
---|---|
author | Calvano, Alexander Timmermann, Lars Loehrer, Philipp Alexander Oehrn, Carina Renate Weber, Immo |
author_facet | Calvano, Alexander Timmermann, Lars Loehrer, Philipp Alexander Oehrn, Carina Renate Weber, Immo |
author_sort | Calvano, Alexander |
collection | PubMed |
description | Acoustic stimulation can improve motor symptoms in Parkinson’s disease (PD) and might therefore represent a potential non-invasive treatment option. Scalp electroencephalography studies in healthy subjects indicate that specifically binaural beat stimulation (BBS) in the gamma frequency range is associated with synchronized cortical oscillations at 40 Hertz (Hz). Several studies suggest that oscillations in the gamma-frequency range (>30 Hz) serve a prokinetic function in PD. In this double-blind, randomized study, 25 PD patients were recruited. The study was conducted with (ON) and without dopaminergic medication (OFF). Each drug condition consisted of two phases (no stimulation and acoustic stimulation). The acoustic stimulation phase was divided into two blocks including BBS and conventional acoustic stimulation (CAS) as a control condition. For BBS, a modulated frequency of 35 Hz was used (left: 320 Hz; right: 355 Hz) and for CAS 340 Hz on both sides. We assessed effects on motor performance using Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and two validated commercially available portable devices (Kinesia ONE™ and Kinesia 360™) measuring motor symptoms such as dyskinesia, bradykinesia, and tremor. Repeated measures ANOVA revealed that BBS improved resting tremor on the side of the more affected limb in the OFF condition, as measured by wearables (F((2,48)) = 3.61, p = 0.035). However, BBS did not exert a general positive effect on motor symptoms as assessed via MDS-UPDRS (F((2,48)) = 1.00, p = 0.327). For CAS, we did not observe an improvement in specific symptoms but rather an overall beneficial effect on motor performance (MDS-UPDRS total score OFF medication: F((2,48)) = 4.17, p = 0.021; wearable scores: F((2,48)) = 2.46, p = 0.097). In this study, we found an improvement of resting tremor when applying BBS in the gamma frequency band OFF medication. Moreover, the positive effects of CAS underline the general positive potential for improvement of motor function by acoustically supported therapeutic approaches. However, more studies are needed to fully characterize the clinical relevance of BBS and to further optimize its ameliorating effects. |
format | Online Article Text |
id | pubmed-10196363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101963632023-05-20 Binaural acoustic stimulation in patients with Parkinson’s disease Calvano, Alexander Timmermann, Lars Loehrer, Philipp Alexander Oehrn, Carina Renate Weber, Immo Front Neurol Neurology Acoustic stimulation can improve motor symptoms in Parkinson’s disease (PD) and might therefore represent a potential non-invasive treatment option. Scalp electroencephalography studies in healthy subjects indicate that specifically binaural beat stimulation (BBS) in the gamma frequency range is associated with synchronized cortical oscillations at 40 Hertz (Hz). Several studies suggest that oscillations in the gamma-frequency range (>30 Hz) serve a prokinetic function in PD. In this double-blind, randomized study, 25 PD patients were recruited. The study was conducted with (ON) and without dopaminergic medication (OFF). Each drug condition consisted of two phases (no stimulation and acoustic stimulation). The acoustic stimulation phase was divided into two blocks including BBS and conventional acoustic stimulation (CAS) as a control condition. For BBS, a modulated frequency of 35 Hz was used (left: 320 Hz; right: 355 Hz) and for CAS 340 Hz on both sides. We assessed effects on motor performance using Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and two validated commercially available portable devices (Kinesia ONE™ and Kinesia 360™) measuring motor symptoms such as dyskinesia, bradykinesia, and tremor. Repeated measures ANOVA revealed that BBS improved resting tremor on the side of the more affected limb in the OFF condition, as measured by wearables (F((2,48)) = 3.61, p = 0.035). However, BBS did not exert a general positive effect on motor symptoms as assessed via MDS-UPDRS (F((2,48)) = 1.00, p = 0.327). For CAS, we did not observe an improvement in specific symptoms but rather an overall beneficial effect on motor performance (MDS-UPDRS total score OFF medication: F((2,48)) = 4.17, p = 0.021; wearable scores: F((2,48)) = 2.46, p = 0.097). In this study, we found an improvement of resting tremor when applying BBS in the gamma frequency band OFF medication. Moreover, the positive effects of CAS underline the general positive potential for improvement of motor function by acoustically supported therapeutic approaches. However, more studies are needed to fully characterize the clinical relevance of BBS and to further optimize its ameliorating effects. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196363/ /pubmed/37213909 http://dx.doi.org/10.3389/fneur.2023.1167006 Text en Copyright © 2023 Calvano, Timmermann, Loehrer, Oehrn and Weber. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Calvano, Alexander Timmermann, Lars Loehrer, Philipp Alexander Oehrn, Carina Renate Weber, Immo Binaural acoustic stimulation in patients with Parkinson’s disease |
title | Binaural acoustic stimulation in patients with Parkinson’s disease |
title_full | Binaural acoustic stimulation in patients with Parkinson’s disease |
title_fullStr | Binaural acoustic stimulation in patients with Parkinson’s disease |
title_full_unstemmed | Binaural acoustic stimulation in patients with Parkinson’s disease |
title_short | Binaural acoustic stimulation in patients with Parkinson’s disease |
title_sort | binaural acoustic stimulation in patients with parkinson’s disease |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196363/ https://www.ncbi.nlm.nih.gov/pubmed/37213909 http://dx.doi.org/10.3389/fneur.2023.1167006 |
work_keys_str_mv | AT calvanoalexander binauralacousticstimulationinpatientswithparkinsonsdisease AT timmermannlars binauralacousticstimulationinpatientswithparkinsonsdisease AT loehrerphilippalexander binauralacousticstimulationinpatientswithparkinsonsdisease AT oehrncarinarenate binauralacousticstimulationinpatientswithparkinsonsdisease AT weberimmo binauralacousticstimulationinpatientswithparkinsonsdisease |